Automate your cell therapy final formulation processes for precision
A purpose-built, automated system for cell therapy fill and finish
For cell and gene therapy developers, manual processes during the final steps in cell therapy manufacturing can lead to product variability, contamination, and other critical risks.
But with the Finia™ Fill and Finish System from Terumo Blood and Cell Technologies, developers can finish strong with an automated cell therapy filling device that provides consistent, high-quality results for both suspension cells and adherent cells.
Finia reduces risks at every step …
Unlike solutions that may automate some, but not all, of the cell therapy fill and finish steps, Finia is a functionally closed benchtop system that fully automates every stage, helping to eliminate risks that affect product quality.
Automated mixing, cooling, and air removal
Automated aliquoting, cryoprotectant addition, and sealing
Automated documentation and data management
… And delivers proven performance at scale
As part of our cell therapy technologies suite of solutions, Finia supports manufacturing scale-up, as well.
One study found Finia performed four sequential runs to process a large-volume harvest of T cells, maintaining dose accuracy and cell concentration, viability, functionality, and phenotype in all product bags. The automated process also reduced operator hands-on time by 60%.